Difference between revisions of "Introduction"

no edit summary
Line 154: Line 154:
{{qnq|But it’s not all so obvious...}}
{{qnq|But it’s not all so obvious...}}


...because epistemology evolves continually, even in medicine:
...because epistemology evolves continually, even in medicine:<blockquote>'''P-value''': In medicine, for example, we rely on statistical inference to confirm experimental results, specifically the {{Tooltip|P-value|2=The p-value represents the probability that observed results are due to chance, assuming the null hypothesis <math> H_0 </math> is true. It should not be used as a binary criterion (e.g., <math> p < 0.05 </math>) for scientific decisions, as values near the threshold require additional verification, such as cross-validation. ''p-hacking'' (repeating tests to achieve significance) increases false positives. Rigorous experimental design and transparency about all tests conducted can mitigate this risk. Type I error increases with multiple tests: for <math> N </math> independent tests at threshold <math> \alpha </math>, the Family-Wise Error Rate (FWER) is <math> FWER = 1 - (1 - \alpha)^N </math>. Bonferroni correction divides the threshold by the number of tests, <math> p < \frac{\alpha}{N} </math>, but can increase false negatives. The False Discovery Rate (FDR) by Benjamini-Hochberg is less conservative, allowing more true discoveries with an acceptable proportion of false positives. The Bayesian approach uses prior knowledge to balance prior and data with a posterior distribution, offering a valid alternative to the p-value. To combine p-values from multiple studies, meta-analysis uses methods like Fisher's: <math> \chi^2 = -2 \sum \ln(p_i) </math>. In summary, the p-value remains useful when contextualized and integrated with other measures, such as confidence intervals and Bayesian approaches.}}, a "significance test" that assesses data validity. Yet, even this entrenched concept is now being challenged. A recent study highlighted a campaign in the journal "Nature" against the use of the P-value.<ref name=":1" /> Signed by over 800 scientists, this campaign marks a "silent revolution" in statistical inference, encouraging a reflective and modest approach to significance.<ref name=":2" /><ref name=":3" /><ref name=":4" /> The American Statistical Association contributed to this discussion by releasing a special issue of "The American Statistician Association" titled "Statistical Inference in the 21st Century: A World Beyond p < 0.05." It offers new ways to express research significance and embraces uncertainty.<ref name="wasser" /></blockquote>
 
{|
{|
|-
|-
|
|
*'''P-value''': In medicine, for example, we rely on statistical inference to confirm experimental results, specifically the {{Tooltip|P-value|2=The p-value represents the probability that observed results are due to chance, assuming the null hypothesis <math> H_0 </math> is true. It should not be used as a binary criterion (e.g., <math> p < 0.05 </math>) for scientific decisions, as values near the threshold require additional verification, such as cross-validation. ''p-hacking'' (repeating tests to achieve significance) increases false positives. Rigorous experimental design and transparency about all tests conducted can mitigate this risk. Type I error increases with multiple tests: for <math> N </math> independent tests at threshold <math> \alpha </math>, the Family-Wise Error Rate (FWER) is <math> FWER = 1 - (1 - \alpha)^N </math>. Bonferroni correction divides the threshold by the number of tests, <math> p < \frac{\alpha}{N} </math>, but can increase false negatives. The False Discovery Rate (FDR) by Benjamini-Hochberg is less conservative, allowing more true discoveries with an acceptable proportion of false positives. The Bayesian approach uses prior knowledge to balance prior and data with a posterior distribution, offering a valid alternative to the p-value. To combine p-values from multiple studies, meta-analysis uses methods like Fisher's: <math> \chi^2 = -2 \sum \ln(p_i) </math>. In summary, the p-value remains useful when contextualized and integrated with other measures, such as confidence intervals and Bayesian approaches.}}, a "significance test" that assesses data validity. Yet, even this entrenched concept is now being challenged. A recent study highlighted a campaign in the journal "Nature" against the use of the P-value.<ref>{{cita libro  
*'''P-value''': In medicine, for example, we rely on statistical inference to confirm experimental results, specifically the {{Tooltip|P-value|2=The p-value represents the probability that observed results are due to chance, assuming the null hypothesis <math> H_0 </math> is true. It should not be used as a binary criterion (e.g., <math> p < 0.05 </math>) for scientific decisions, as values near the threshold require additional verification, such as cross-validation. ''p-hacking'' (repeating tests to achieve significance) increases false positives. Rigorous experimental design and transparency about all tests conducted can mitigate this risk. Type I error increases with multiple tests: for <math> N </math> independent tests at threshold <math> \alpha </math>, the Family-Wise Error Rate (FWER) is <math> FWER = 1 - (1 - \alpha)^N </math>. Bonferroni correction divides the threshold by the number of tests, <math> p < \frac{\alpha}{N} </math>, but can increase false negatives. The False Discovery Rate (FDR) by Benjamini-Hochberg is less conservative, allowing more true discoveries with an acceptable proportion of false positives. The Bayesian approach uses prior knowledge to balance prior and data with a posterior distribution, offering a valid alternative to the p-value. To combine p-values from multiple studies, meta-analysis uses methods like Fisher's: <math> \chi^2 = -2 \sum \ln(p_i) </math>. In summary, the p-value remains useful when contextualized and integrated with other measures, such as confidence intervals and Bayesian approaches.}}, a "significance test" that assesses data validity. Yet, even this entrenched concept is now being challenged. A recent study highlighted a campaign in the journal "Nature" against the use of the P-value.<ref name=":1">{{cita libro  
  | autore = Amrhein V
  | autore = Amrhein V
  | autore2 = Greenland S
  | autore2 = Greenland S
Line 174: Line 173:
  | DOI = 10.1038/d41586-019-00857-9
  | DOI = 10.1038/d41586-019-00857-9
  | OCLC =  
  | OCLC =  
  }} Mar;567(7748):305-307.</ref> Signed by over 800 scientists, this campaign marks a "silent revolution" in statistical inference, encouraging a reflective and modest approach to significance.<ref>{{cita libro  
  }} Mar;567(7748):305-307.</ref> Signed by over 800 scientists, this campaign marks a "silent revolution" in statistical inference, encouraging a reflective and modest approach to significance.<ref name=":2">{{cita libro  
  | autore = Rodgers JL
  | autore = Rodgers JL
  | titolo = The epistemology of mathematical and statistical modeling: a quiet methodological revolution
  | titolo = The epistemology of mathematical and statistical modeling: a quiet methodological revolution
Line 187: Line 186:
  | DOI = 10.1037/a0018326
  | DOI = 10.1037/a0018326
  | OCLC =  
  | OCLC =  
  }} Jan;65(1):1-12.</ref><ref>{{cita libro  
  }} Jan;65(1):1-12.</ref><ref name=":3">{{cita libro  
  | autore = Meehl P
  | autore = Meehl P
  | titolo = The problem is epistemology, not statistics: replace significance tests by confidence intervals and quantify accuracy of risky numerical predictions
  | titolo = The problem is epistemology, not statistics: replace significance tests by confidence intervals and quantify accuracy of risky numerical predictions
Line 200: Line 199:
  | DOI =  
  | DOI =  
  | OCLC =  
  | OCLC =  
  }}</ref><ref>{{cita libro  
  }}</ref><ref name=":4">{{cita libro  
  | autore = Sprenger J
  | autore = Sprenger J
  | autore2 = Hartmann S
  | autore2 = Hartmann S
Editor, Editors, USER, admin, Bureaucrats, Check users, dev, editor, founder, Interface administrators, member, oversight, Suppressors, Administrators, translator
11,119

edits